Uniplan Investment Counsel’s Bristol-Myers Squibb BMY Stock Holding History

Uniplan Investment Counsel’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-55,619	Closed	-$3.29M	–	133
2021 Q3	$3.29M	Sell	55,619 -168	-0.3%	-$11.1K	0.2%	88
2021 Q2	$3.73M	Sell	55,787 -3,228	-5%	-$210K	0.22%	89
2021 Q1	$3.73M	Sell	59,015 -3,861	-6%	-$240K	0.24%	79
2020 Q4	$3.9M	Sell	62,876 -5,440	-8%	-$335K	0.27%	71
2020 Q3	$4.12M	Sell	68,316 -4,546	-6%	-$274K	0.29%	61
2020 Q2	$4.28M	Sell	72,862 -11,618	-14%	-$695K	0.3%	59
2020 Q1	$4.71M	Buy	84,480 +6,138	+8%	+$375K	0.35%	53
2019 Q4	$5.03M	Buy	+78,342	New	+$4.49M	0.3%	62

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Uniplan Investment Counsel's BMY Position: Q4 2021 in Review

Uniplan Investment Counsel sold out of Bristol-Myers Squibb (BMY) in Q4 2021, closing a stake of 55,619 shares — an estimated $3.29M sold.

Uniplan Investment Counsel first reported a position in BMY in Q4 2019 and held it in 8 quarters. The position peaked at $5.03M in Q4 2019. 2,444 funds tracked by Wall St. Rank hold BMY as of Q4 2021.

Uniplan Investment Counsel reported no remaining Bristol-Myers Squibb position as of Q4 2021 after selling out during the quarter.
Uniplan Investment Counsel sold 55,619 Bristol-Myers Squibb shares in Q4 2021, an estimated $3.29M.
Uniplan Investment Counsel first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 8 quarters.
Uniplan Investment Counsel's Bristol-Myers Squibb position peaked at $5.03M in Q4 2019.
2,444 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.

Based on Uniplan Investment Counsel's 13F filing for Q4 2021, filed 14 Feb 2022.